The results suggested that inhibiting PHGDH pharmacologically could inhibit the proliferation of FLT3-ITD+ AML cells and induce apoptosis and potentially involves activation of the Bcl-2/Bax signaling pathway. Here, BCL2 is linked to acute myeloid leukemia.